In the media
Other news
Want to know more about the JLABS Portfolio?
Read full storyOther news
Riding the Start-Up Roller Coaster: What It's Really Like to Be a Healthcare Entrepreneur
Read full storyOther news
IDEAYA Biosciences raised a $94M crossover Series B financing to develop next generation biomarker-enabled synthetic lethality therapies.
Read full storyOther news
Sirenas LLC. annouced today they have entered a muti-target research collaboration agreement with Bristol-Myers Squibb to deploy a drug discovery platform against undisclosed challenging therapeutic targets
Read full storyOther news
Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies
Read full storyOther news
JLABS TMC Company finds Growth in Shrinking Cells
Read full storyOther news
Ensysce Biosciences has received Fast Track designation from the FDA for the development of abuse-resistant opioid drug PF614
Read full storyOther news
Arcturus Therapeutics expands collaboration with Takeda Pharmaceuticals
Read full storyOther news
Congratulations to the JLABS @ TMC Company, Corinnova, Inc. for coming in first place in the RESI San Francisco Innovation Challenge at the 2018 JP Morgan Conference
Read full storyOther news
Kara Bortone, Ph.D., Head of Johnson & JohnsonInnovation, JLABS in San Diego shares why her role is the coolest job in San Diego in San Diego Magazine
Read full storyOther news
Alumni, Batu Biologics, has secured $1.3M in crowdfunding to develop its clinical stage tumor-angiogenesis targeting immunotherapy, ValloVax
Read full storyIn the media
15 Coolest Jobs in San Diego and How to Get Them
Read full storyOther news